Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis

Abstract

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (42)

• A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis via openalex
• Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex
• Dienogest via openalex
• Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
• Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex
• Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
• Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
• Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
• Dienogest in the treatment of endometriosis via openalex
• Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
• Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF via openalex
• Effect of endometriosis on in vitro fertilization via openalex
• Effects of Dienogest on Surgically Induced Endometriosis in Rats after Repeated Oral Administration via openalex
• Endometriosis via openalex
• Endometriosis via openalex
• Endometriosis: pathogenesis and treatment via openalex
• INCIDENCE OF PELVIC ENDOMETRIOSIS IN ROCHESTER, MINNESOTA, 1970–1979 via openalex
• Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
• New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone via openalex
• Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex
• Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
• Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex
• (no identifier) via openalex

Source provenance

openalex

last seen: 2026-05-11T08:51:17.274897+00:00